Publications by authors named "Karol L Thompson"

27Publications

Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.

Toxicol Pathol 2013 19;41(4):662-80. Epub 2012 Oct 19.

Division of Drug Safety Research, Office of Testing and Research, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article and Find Full Text PDF
October 2013

Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.

Toxicol Lett 2012 Sep 22;213(2):285-91. Epub 2012 Jul 22.

Division of Drug Safety Research, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.

View Article and Find Full Text PDF
September 2012

Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.

Int J Toxicol 2012 Jan-Feb;31(1):14-24. Epub 2012 Jan 19.

Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Building 64, Room 2036, Silver Spring, MD 20993, USA.

View Article and Find Full Text PDF
June 2012

An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratories.

BMC Biotechnol 2011 Apr 12;11:38. Epub 2011 Apr 12.

Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993 USA.

View Article and Find Full Text PDF
April 2011

Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.

Cancer Chemother Pharmacol 2010 Jul 14;66(2):303-14. Epub 2009 Nov 14.

Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

View Article and Find Full Text PDF
July 2010

Comparison of the diagnostic performance of human whole genome microarrays using mixed-tissue RNA reference samples.

Toxicol Lett 2009 Apr 7;186(1):58-61. Epub 2008 Sep 7.

Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

View Article and Find Full Text PDF
April 2009

Quality control of microarray assays for toxicogenomic and in vitro diagnostic applications.

Methods Mol Biol 2008 ;460:45-68

Division of Applied Pharmacology Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

View Article and Find Full Text PDF
August 2008

Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.

Toxicol Sci 2008 Jan 13;101(1):159-70. Epub 2007 Oct 13.

Center for Devices and Radiological Health, U.S. Food and Drug Administration, White Oak Life Sciences Laboratory, Silver Spring, MD 20993, USA.

View Article and Find Full Text PDF
January 2008

Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNA.

BMC Biotechnol 2007 Sep 13;7:57. Epub 2007 Sep 13.

Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

View Article and Find Full Text PDF
September 2007

Improvement in the reproducibility and accuracy of DNA microarray quantification by optimizing hybridization conditions.

BMC Bioinformatics 2006 Sep 6;7 Suppl 2:S17. Epub 2006 Sep 6.

Center for Functional Genomics, National Center for Toxicological Research, US FDA, Jefferson, AR 72079, USA.

View Article and Find Full Text PDF
September 2006

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

Authors:
Leming Shi Laura H Reid Wendell D Jones Richard Shippy Janet A Warrington Shawn C Baker Patrick J Collins Francoise de Longueville Ernest S Kawasaki Kathleen Y Lee Yuling Luo Yongming Andrew Sun James C Willey Robert A Setterquist Gavin M Fischer Weida Tong Yvonne P Dragan David J Dix Felix W Frueh Frederico M Goodsaid Damir Herman Roderick V Jensen Charles D Johnson Edward K Lobenhofer Raj K Puri Uwe Schrf Jean Thierry-Mieg Charles Wang Mike Wilson Paul K Wolber Lu Zhang Shashi Amur Wenjun Bao Catalin C Barbacioru Anne Bergstrom Lucas Vincent Bertholet Cecilie Boysen Bud Bromley Donna Brown Alan Brunner Roger Canales Xiaoxi Megan Cao Thomas A Cebula James J Chen Jing Cheng Tzu-Ming Chu Eugene Chudin John Corson J Christopher Corton Lisa J Croner Christopher Davies Timothy S Davison Glenda Delenstarr Xutao Deng David Dorris Aron C Eklund Xiao-hui Fan Hong Fang Stephanie Fulmer-Smentek James C Fuscoe Kathryn Gallagher Weigong Ge Lei Guo Xu Guo Janet Hager Paul K Haje Jing Han Tao Han Heather C Harbottle Stephen C Harris Eli Hatchwell Craig A Hauser Susan Hester Huixiao Hong Patrick Hurban Scott A Jackson Hanlee Ji Charles R Knight Winston P Kuo J Eugene LeClerc Shawn Levy Quan-Zhen Li Chunmei Liu Ying Liu Michael J Lombardi Yunqing Ma Scott R Magnuson Botoul Maqsodi Tim McDaniel Nan Mei Ola Myklebost Baitang Ning Natalia Novoradovskaya Michael S Orr Terry W Osborn Adam Papallo Tucker A Patterson Roger G Perkins Elizabeth H Peters Ron Peterson Kenneth L Philips P Scott Pine Lajos Pusztai Feng Qian Hongzu Ren Mitch Rosen Barry A Rosenzweig Raymond R Samaha Mark Schena Gary P Schroth Svetlana Shchegrova Dave D Smith Frank Staedtler Zhenqiang Su Hongmei Sun Zoltan Szallasi Zivana Tezak Danielle Thierry-Mieg Karol L Thompson Irina Tikhonova Yaron Turpaz Beena Vallanat Christophe Van Stephen J Walker Sue Jane Wang Yonghong Wang Russ Wolfinger Alex Wong Jie Wu Chunlin Xiao Qian Xie Jun Xu Wen Yang Liang Zhang Sheng Zhong Yaping Zong William Slikker

Nat Biotechnol 2006 Sep;24(9):1151-61

National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas 72079, USA.

View Article and Find Full Text PDF
September 2006